首页 | 本学科首页   官方微博 | 高级检索  
     

奎硫平治疗抑郁发作的对照研究
引用本文:王瑛,侯明捷,范华,史晓宁,王传跃. 奎硫平治疗抑郁发作的对照研究[J]. 临床精神医学杂志, 2009, 19(2)
作者姓名:王瑛  侯明捷  范华  史晓宁  王传跃
作者单位:首都医科大学附属北京安定医院,100088
摘    要:目的:探讨奎硫平对抑郁发作的疗效和安全性。方法:收集抑郁发作或复发性抑郁的患者60例,分为奎硫平组和5-羟色胺再摄取抑制剂(SSRIs)组各30例,疗程8周。使用Montgomery-As-berg抑郁量表(MADRS)、汉密尔顿抑郁量表(HAMD)和汉密尔顿焦虑量表(HAMA)评定疗效,以治疗中出现的症状量表(TESS)评定不良反应。结果:治疗8周两组MADRS、HAMD和HAMA量表减分值相仿(P均>0.05),治疗1周末奎硫平组即显示疗效优于SSRIs组(P均<0.05);奎硫平组MADRS量表失眠障碍因子减分值大。治疗8周奎硫平组有效率为25例(83.3%),SSRIs组为26例(86.7%)。奎硫平组无转躁患者,而SSRIs组转躁3例。奎硫平组头晕、口干、便秘的发生率明显多于SSRIs组。结论:奎硫平单药治疗抑郁发作的疗效与SSRIs相当,可改善患者失眠和焦虑症状,头晕、口干、便秘等不良反应较多见。

关 键 词:奎硫平  抑郁发作  5-羟色胺再摄取抑制剂  

A control study of quetiapine in the treatment of depression
WANG Ying,HOU Ming-jie,FAN Hua,SHI Xiao-ning,WANG Chuan-yue. A control study of quetiapine in the treatment of depression[J]. Journal of Clinical Psychological Medicine, 2009, 19(2)
Authors:WANG Ying  HOU Ming-jie  FAN Hua  SHI Xiao-ning  WANG Chuan-yue
Affiliation:WANG Ying,HOU Ming-jie,FAN Hua,SHI Xiao-ning,WANG Chuan-yue.Beijing ,ing Hospital Affiliated to Capital Medical University,Beijing 100088,China
Abstract:Objective:To detect the efficacy and safety of single quetiapine in the treatment of depression. Method:60 patients with depression or recurrent depression were assigned into quetiapine group and selective serotonin reuptake inhibitors(SSRIs)group.Course of treatment was 8 weeks.Montgomery-Asberg depressive scale(MADRS),Hamilton depressive scale(HAMD)and Hamilion anxiety scale(HAMA)were applied to evaluate efficacy,and treatment emergent symptoms scale(TESS)was applied to evaluate side-effect of drugs. Resu...
Keywords:quetipine  depression  SSRIs  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号